Excellere Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Excellere Partners has acquired 1 company. It has also invested in 1 other.

Excellere Partners’ most common sectors for investment arehealthcare services (31%) and life science (14%) . The Firm’s most common investment types include growth capital (57%) and buyout (lbo, mbo, mbi) (31%). In total, Excellere Partners has invested in 20 US states.

In the last 3 years, Excellere Partners has exited 2 companies. The Firm’s most common exit type is secondary buyout (60%). Excellere Partners’ largest (disclosed) exit occurred in 2012 when it sold MTS Medication Technologies for $158M.

Join Mergr to view Excellere Partners’ full profile and discover more large private equity firm investors just like it.

M&A Summary

  • M&A Total Activity33
    • M&A Buy Activity23
    • M&A Sell Activity10
  • Total Sectors Invested 12
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 5
  • M&A Advisors 2

Excellere Partners

3033 East First Avenue, Suite #700,
Denver, Colorado 80206
United States
(303) 765-2400
www.excellerepartners.com
dkessenich@excellerepartners.com

Excellere Partners is a private equity firm focused on mid-market recapitalizations, management buyouts, and consolidation opportunities. Excellere looks to partner with management on transactions and targets opportunities in business services, education/training, healthcare, industrial services, and specialty foods. Excellere Partners was formed in 2006 and is based in Denver, Colorado.


Investment Criteria

Sectors of Interest: Building Materials, Business Services, Education, Energy Services and Equipment, Environmental, Food, Healthcare Services, Information Technology, Insurance, Internet Software and Services, Life Science, Machinery, Manufacturing, Medical Products, Software, Test/Measurement Equipment, Utilities

Target Transaction Types: Buyout (LBO, MBO, MBI), Consolidation, Growth Capital, Recapitalization, Venture

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA 7 -
Investment Size - -
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '18 '19 '20 '21 '22 '23 T
Buy (0.8/yr) # 19 2 1 1 - - 23
Sell (0.4/yr) # 8 - 1 1 - - 10
vol $158M $158M
  33

Most Recent M&A

Company Date Value Type
Biocare Medical LLC 2021-12-09 - Secondary Sale
Pacheco, California · www.biocare.net
SCA Pharmaceuticals LLC 2021-01-21 - Secondary Buyout
Little Rock, Arkansas · www.scapharma.com
Two Labs LLC 2020-11-12 - Trade Sale
Powell, Ohio · www.twolabs.com
ParcelShield LLC 2020-03-10 - Growth Capital
Redmond, Oregon · www.parcelshield.com
Sepro Corp. 2019-02-12 - Growth Capital
Carmel, Indiana · www.sepro.com
Concord Technologies 2019-01-30 - Growth Capital
Seattle, Washington · www.concord.net
TrialCard, Inc. 2017-11-14 - Secondary Sale
Morrisville, North Carolina · www.trialcard.com
Biocare Medical LLC 2017-08-25 - Growth Capital
Pacheco, California · www.biocare.net
North Oakland Dermatology 2017-06-05 - Growth Capital
Rochester Hills, Michigan
Medlogix, Inc. 2017-06-05 - Growth Capital
Lansdale, Pennsylvania · www.medlogix.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 1 (13%) - 7 (30%) -
Life Science 2 (25%) - 3 (13%) -
Energy Services and Equipment 1 (13%) - 2 (9%) -
Environmental 1 (13%) - 2 (9%) -
Insurance 1 (13%) - 2 (9%) -
Business Services - - 1 (4%) -
Education - - 1 (4%) -
Engineering - - 1 (4%) -
Information Technology 1 (13%) - 1 (4%) -
Internet Software and Services 1 (13%) - 1 (4%) -
Medical Products - - 1 (4%) -
Test/Measurement Equipment - - 1 (4%) -
Total 8 - 23 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 8 (100%) - 23 (100%) -
  Texas 2 (25%) - 2 (9%) -
  Ohio 1 (13%) - 2 (9%) -
  California - - 2 (9%) -
  Washington 1 (13%) - 1 (4%) -
  Pennsylvania 1 (13%) - 1 (4%) -
  Oregon 1 (13%) - 1 (4%) -
  Indiana 1 (13%) - 1 (4%) -
  Arkansas 1 (13%) - 1 (4%) -
  Wisconsin - - 1 (4%) -
  West Virginia - - 1 (4%) -
  Virginia - - 1 (4%) -
  Tennessee - - 1 (4%) -
  North Carolina - - 1 (4%) -
  Minnesota - - 1 (4%) -
  Michigan - - 1 (4%) -
  Kansas - - 1 (4%) -
  Georgia - - 1 (4%) -
  Florida - - 1 (4%) -
  Colorado - - 1 (4%) -
  Arizona - - 1 (4%) -
Total 8 - 23 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 6 (75%) - 13 (57%) -
Buyout (LBO, MBO, MBI) 1 (13%) - 7 (30%) -
Going Private - - 1 (4%) -
Recapitalization - - 1 (4%) -
Secondary Buyout 1 (13%) - 1 (4%) -
Total 8 - 23 -

Exits by Deal Type

Type Total # Value
Secondary Sale 6 (60%) -
Trade Sale - Public Company 2 (20%) 158M (100%)
Trade Sale 2 (20%) -
Total 10 $158M

Top M&A Advisors

Financial Deals
Jefferies
 2
Legal Deals
Hogan Lovells
 1

Deal Values

sell # Total
$100M to $1B 1 $158M
TOTAL $158M
Largest MTS Medication Technologies, Inc.
$158M (2012-05-22)

M&A Connections

Deals
Acquired from
Investor(s)
4%
1 (4%)
Exited to
Investor(s)
60%
6 (60%)
Strategic(s)
40%
4 (40%)

Investor Summary

Investor Type

Private Equity Firm

Size

Large

PE Assets

1.4B USD

Established

2006

Specialist/Generalist

Generalist

Leadership

Brad Cornell

Managing Partner

Matthew Hicks

Managing Partner

Patrick O'Keefe

Managing Partner

Ryan Glaws

Managing Partner

Jacque Vedra

CFO

FAQ

When was Excellere Partners founded?

Excellere Partners was founded in 2006.

What type of investor is Excellere Partners?

Excellere Partners is a private equity firm.

Where is Excellere Partners headquartered?

Excellere Partners is headquartered in Denver, Colorado.

How much capital does Excellere Partners have under management?

Excellere Partners has 1.4B USD under management.

 Subscribe to unlock this and 197,084
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 188K M&A Transactions
  • 193K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 74K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal